Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-05
DOI
10.1038/s41598-018-22787-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study
- (2017) Yi Ji et al. INTERNATIONAL JOURNAL OF CANCER
- Infantile haemangioma
- (2017) Christine Léauté-Labrèze et al. LANCET
- Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma
- (2017) Kyu Han Kim et al. JAMA Dermatology
- Ulcerated infantile haemangiomas: the effect of the selective beta-blocker atenolol on wound healing
- (2016) G. Ruitenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Jagged1/Notch3 Signaling Modulates Hemangioma-Derived Pericyte Proliferation and Maturation
- (2016) Yi Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Safety of Propranolol Therapy for Severe Infantile Hemangioma
- (2016) Sorilla Prey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial
- (2016) Hesham Zaher et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral atenolol therapy for proliferating infantile hemangioma
- (2016) Yi Ji et al. MEDICINE
- Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma
- (2016) Peter Frommelt et al. PEDIATRIC DERMATOLOGY
- Rebound Growth of Infantile Hemangiomas After Propranolol Therapy
- (2016) S. D. Shah et al. PEDIATRICS
- Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
- (2016) C. Leaute-Labreze et al. PEDIATRICS
- Propranolol
- (2015) Yi Ji et al. ANNALS OF SURGERY
- Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol
- (2015) José Bernabeu-Wittel et al. PEDIATRIC DERMATOLOGY
- Diagnosis and Management of Infantile Hemangioma
- (2015) D. H. Darrow et al. PEDIATRICS
- Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
- (2015) Naikhoba C.O. Munabi et al. Stem Cells Translational Medicine
- The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action
- (2014) Y. Ji et al. BRITISH JOURNAL OF DERMATOLOGY
- Propranolol targets the contractility of infantile haemangioma-derived pericytes
- (2014) D. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful treatment of oral itraconazole for infantile hemangiomas: A case series
- (2014) Yuping Ran et al. JOURNAL OF DERMATOLOGY
- Signaling pathways in the development of infantile hemangioma
- (2014) Yi Ji et al. Journal of Hematology & Oncology
- Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study
- (2014) Álvaro Abarzúa-Araya et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Propranolol vs Prednisolone for Symptomatic Proliferating Infantile Hemangiomas
- (2014) Nancy M. Bauman et al. JAMA Otolaryngology-Head & Neck Surgery
- Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells
- (2013) Y. Ji et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of Infantile Hemangiomas with Sirolimus in a Patient with PHACE Syndrome
- (2013) Samer Kaylani et al. PEDIATRIC DERMATOLOGY
- Propranolol Treatment of Infantile Hemangiomas: Anticipatory Guidance for Parents and Caretakers
- (2013) Kari Martin et al. PEDIATRIC DERMATOLOGY
- Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol
- (2012) E. Pope et al. BRITISH JOURNAL OF DERMATOLOGY
- Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells
- (2012) Yi Ji et al. JOURNAL OF PEDIATRIC SURGERY
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
- (2012) B. A. Drolet et al. PEDIATRICS
- Atenolol: A promising alternative to propranolol for the treatment of hemangiomas
- (2011) Martine F. Raphaël et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants
- (2011) Marlies de Graaf et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Management of infantile subglottic hemangioma: Acebutolol or propranolol?
- (2010) Catherine Blanchet et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Expression of components of the renin–angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution
- (2010) Tinte Itinteang et al. Journal of Plastic Reconstructive and Aesthetic Surgery
- Propranolol for Severe Hemangiomas of Infancy
- (2008) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth Characteristics of Infantile Hemangiomas: Implications for Management
- (2008) L. C. Chang et al. PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started